SG11202007135SA - Method for analysing pluripotent stem cell biomarkers, and implementations thereof - Google Patents
Method for analysing pluripotent stem cell biomarkers, and implementations thereofInfo
- Publication number
- SG11202007135SA SG11202007135SA SG11202007135SA SG11202007135SA SG11202007135SA SG 11202007135S A SG11202007135S A SG 11202007135SA SG 11202007135S A SG11202007135S A SG 11202007135SA SG 11202007135S A SG11202007135S A SG 11202007135SA SG 11202007135S A SG11202007135S A SG 11202007135SA
- Authority
- SG
- Singapore
- Prior art keywords
- analysing
- implementations
- stem cell
- pluripotent stem
- cell biomarkers
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
- 210000001778 pluripotent stem cell Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201821022052 | 2018-06-13 | ||
IN201821046670 | 2018-12-10 | ||
PCT/IN2019/050453 WO2019239431A1 (en) | 2018-06-13 | 2019-06-13 | Method for analysing pluripotent stem cell biomarkers, and implementations thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202007135SA true SG11202007135SA (en) | 2020-12-30 |
Family
ID=67003579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202007135SA SG11202007135SA (en) | 2018-06-13 | 2019-06-13 | Method for analysing pluripotent stem cell biomarkers, and implementations thereof |
Country Status (9)
Country | Link |
---|---|
US (2) | US11926875B2 (en) |
EP (1) | EP3735475A1 (en) |
JP (2) | JP2021526812A (en) |
KR (1) | KR20210020045A (en) |
CN (1) | CN112262219A (en) |
AU (1) | AU2019285572B2 (en) |
CA (1) | CA3103714A1 (en) |
SG (1) | SG11202007135SA (en) |
WO (1) | WO2019239431A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1852974A (en) * | 2003-06-09 | 2006-10-25 | 密歇根大学董事会 | Compositions and methods for treating and diagnosing cancer |
JP2010178650A (en) * | 2009-02-04 | 2010-08-19 | Univ Of Tokyo | Test method for predicting recurrence of solid cancer and recurrence prophylactic |
US20130296183A1 (en) * | 2010-09-17 | 2013-11-07 | President And Fellows Of Harvard College | Functional genomics assay for characterizing pluripotent stem cell utility and safety |
-
2019
- 2019-06-13 WO PCT/IN2019/050453 patent/WO2019239431A1/en unknown
- 2019-06-13 JP JP2020568365A patent/JP2021526812A/en active Pending
- 2019-06-13 AU AU2019285572A patent/AU2019285572B2/en active Active
- 2019-06-13 CN CN201980038677.5A patent/CN112262219A/en active Pending
- 2019-06-13 KR KR1020207038012A patent/KR20210020045A/en unknown
- 2019-06-13 CA CA3103714A patent/CA3103714A1/en active Pending
- 2019-06-13 EP EP19733154.9A patent/EP3735475A1/en active Pending
- 2019-06-13 SG SG11202007135SA patent/SG11202007135SA/en unknown
-
2020
- 2020-08-13 US US16/993,226 patent/US11926875B2/en active Active
-
2023
- 2023-12-12 US US18/536,401 patent/US20240254562A1/en active Pending
-
2024
- 2024-02-02 JP JP2024014812A patent/JP2024054187A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20240254562A1 (en) | 2024-08-01 |
CN112262219A (en) | 2021-01-22 |
US11926875B2 (en) | 2024-03-12 |
AU2019285572B2 (en) | 2024-09-12 |
AU2019285572A1 (en) | 2020-08-20 |
KR20210020045A (en) | 2021-02-23 |
JP2024054187A (en) | 2024-04-16 |
JP2021526812A (en) | 2021-10-11 |
EP3735475A1 (en) | 2020-11-11 |
CA3103714A1 (en) | 2019-12-19 |
US20200370134A1 (en) | 2020-11-26 |
WO2019239431A1 (en) | 2019-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3568508A4 (en) | Methods for analyzing t cell receptors and b cell receptors | |
EP3674689A4 (en) | Gas analyzer and gas analyzing method | |
IL276345A (en) | Devices, methods and kits for sample characterization | |
EP3764425A4 (en) | Separator for electrochemical device, and manufacturing method therefor | |
HK1257561A1 (en) | Immortalized stem cells, and method for producing same | |
EP3638987A4 (en) | Devices and methods for cell analysis | |
EP3453753A4 (en) | Method for subculturing pluripotent stem cells | |
SG10201707034YA (en) | Cartridge for sample analysis, production method thereof, and use thereof | |
IL278022A (en) | Microfluidic method for single cell analysis | |
EP3176253A4 (en) | Method for evaluating quality of human mesenchymal stem cell, and monoclonal antibody for use in said method | |
GB2562858B (en) | Method for the cytometric analysis of cell samples | |
SG11201912436PA (en) | Method for predicting differentiation ability of pluripotent stem cell, and reagent for same | |
IL265980A (en) | Undifferentiated stem cell-removing agent, and method for removing undifferentiated stem cells | |
MX2018016196A (en) | Method for sampling gingival metabolites. | |
IL281751A (en) | Methods for differentiating mesenchymal stem cells | |
SG11202001138PA (en) | Method for determining undifferentiated state of pluripotent stem cell, method for subculturing pluripotent stem cell, and device for use in the methods | |
EP3812467A4 (en) | Method for analyzing behavior of cells, and use thereof | |
EP3767294A4 (en) | Reagent kit, measurement kit, and measurement method | |
EP3508569A4 (en) | Method for obtaining microglia from pluripotent stem cells | |
GB201620195D0 (en) | Electrochemical cell assembly and method for operation of the same | |
HUE065324T2 (en) | Battery electrode analysis method | |
SG11201706114RA (en) | Method for isolating, removing and analyzing cells | |
HUE064617T2 (en) | Separator for electrochemical device, method for manufacturing same, and electrochemical device comprising same | |
EP3767293A4 (en) | Reagent kit, measurement kit, and measurement method | |
LT3574303T (en) | Method and device for analysing cells |